New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

May 27, 2021
£30 million is to be invested in postgraduate training courses for doctors, to ensure the NHS has access to skills necessary in managing the patient care backlog from the pandemic. Many postgraduate trainees have postponed their study in order to work on the frontline. This funding will be manifested in a tailored approach, based on the individual needs of trainees, including one-to-one training conversations and recovery plans. As many as 123,800 doctors and over 303,000 nurses are now wo...
Read More
May 26, 2021
BIVDA Digital Working Party Reminder Register here.  10:30     Welcome, introductions and competition law      10.35     Overview of the IVD development pathway and how CPI can help commercialise digital IVD devices using their in-house capabilities and expertise          UK CPI (catapult)10.55   Digital Revolution Industry paper final drafting Helen Dent, BIVDA11.35&...
Read More
May 26, 2021
Press Release                                                                                 &...
Read More
May 25, 2021
A new national public health procurement scheme has gone live to speed up access to supplies and build threat resilience. The new microbiology framework will help to grow capacity, push innovation and build resilience within the microbiology supply chain. The framework is open to all public sector, academic and charitable bodies. It will help to ensure labs and other diagnostic and treatment services have easier and faster access to essential supplies. The framework was designed by Public Health...
Read More
May 21, 2021
The British In-Vitro Diagnostic Association (BIVDA) has launched the first in a series of strategy papers, which will assess what the UK IVD industry needs to grow and thrive in the future. The first of these papers ’Emerging from the Pandemic – An Industry View’ examines what needs to be done to lock in our progress in developing systems to cope with infectious diseases. The outbreak of SARS-CoV-2 first detected in China in December 2019 has been challenging for countries...
Read More
May 19, 2021
The Government is preparing to launch trade agreement negotiations with Canada and Mexico in the latest phase of post-Brexit consolidation of global trade relationships. A call for input is being put out to UK businesses and the public ahead of the talks formally starting. Consultation with a wide variety of trading stakeholders, citizens and industry bodies will allow for the UK to put its best foot forward at the talks, which are scheduled to begin later this year. In 2020, the UK agreed deals...
Read More
May 19, 2021
NHS Confederation has announced the launch of a new network for GP Federations as it seeks to unite federation managers across the UK and support members with tailored products such as bulletins, briefings and events. This will allow chairs, chief operating officers, and other senior federation managers to interconnect, co-operate on issues and share resources. Ensuring the ongoing support of primary care during the pandemic, while it copes with the NHS backlog from lockdown pauses, will be an e...
Read More
May 18, 2021
The United Kingdom has shared some objectives for the COP26 event in November with Central American countries in a regional event. The British Ambassador in Guatemala, Nick Whittingham, led discussion from the UK side at the virtual opening of the French – Central American talks on climate change, organized by the Government of France, the Guatemalan Ministry of Foreign Affairs and the countries of the System of Central American Integration (SICA). The UK will host the 26th UN Climate Chan...
Read More
May 13, 2021
IPSWICH, MA (May 10th, 2021) — New England Biolabs, Inc. (NEB®), a leading supplier of life science reagents, today announces that it has entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB. With the point-of-care market becoming more focused on the development of robust, accurate and cost-effective diagnostic tests for use outsi...
Read More
May 11, 2021
BIVDA Chief Executive Doris-Ann Williams and Chief Operating Officer Helen Dent have commented on the publication of the Health and Care Bill in today’s Queen’s Speech.  Commenting on plans to promote integrated care in the health service, Doris-Ann said; “The new White Paper offers an opportunity to promote joint working and collaboration in the NHS across different teams, department and disciplines. As part of these reforms, we want to see greater use of IVDs in pri...
Read More
Page 21 of 34 [21]

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858